 This local, non-interventional, cohort study of patients with metastatic colorectal cancer mCRC will prospectively collect data from standard clinical practice of second-line treatment with chemotherapy plus Avastin bevacizumab. There will be no additional diagnostic or therapeutic procedures required by this study, apart from those performed in everyday clinical practice for second-line treatment of mCRC in Croatia. 